ICCC
ImmuCellFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
Composite grade F from latest DB weights. Momentum 5.3 / Value 59.4
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.4.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
5
Value
59
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Why
Momentum5 · Δ7d -
Value59 · Δ7d +0.4
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
5
52% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
59
48% active weight
Current posture
7d trendFlat
Δ7d
+0.4
Δ21d
-0.1
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 5.3 / Value 59.4
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$87.48M
Beta
0.31
Shares Out
9.05M
P/E (TTM)
23.4
P/S (TTM)
1.97
P/FCF (TTM)
76.50
Rev YoY
-8.4%
EPS YoY
+82.0%
Gross Margin
+40.9%
Op Margin
+9.9%
Net Debt
$6.78M
Current Ratio
4.21
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology